You are here

  • Home
  • Archive
  • Volume 12, Issue 1
  • Correction: PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1

Article metrics

Article menu

See original article:

Download PDFPDF

Correction
Correction: PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a multiomics analysis

 

Online download statistics by month:

Online download statistics by month: January 2024 to August 2025

AbstractFullPdf
Jan 2024016032
Feb 202406413
Mar 202405320
Apr 20240518
May 20240329
Jun 20240389
Jul 202402916
Aug 20240237
Sep 20240526
Oct 20240207
Nov 20240217
Dec 202402910
Jan 20250135
Feb 20250166
Mar 20250105
Apr 20250278
May 202501110
Jun 20250207
Jul 2025020
Aug 2025010
Total0672185